Evidence map›Paper›PMID 35458471›Full record

ArticleViruses2022

No Evidence for Orthohepevirus C in Archived Human Samples in Germany, 2000-2020.

Mirko Faber, Jürgen J Wenzel, Monika Erl, Klaus Stark, Mathias Schemmerer

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. First Evidence of Spillover ofTransboundary and emerging diseases · 2025
    Article
  5. Article
  6. Rat hepatitis E virus (Emerging microbes & infections · 2024
    Article
  7. Cell binding tropism of rat hepatitis E virus is a pivotal determinant of its zoonotic transmission to humans.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Microorganisms · 2023
    Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mirko FaberDepartment for Infectious Disease Epidemiology, Robert Koch Institute, 10437 Berlin, Germany.ORCID 0000-0002-9196-570X
Jürgen J WenzelNational Consultant Laboratory for HAV and HEV, Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-8422-6581
Monika ErlNational Consultant Laboratory for HAV and HEV, Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, 93053 Regensburg, Germany.
Klaus StarkDepartment for Infectious Disease Epidemiology, Robert Koch Institute, 10437 Berlin, Germany.
Mathias SchemmererNational Consultant Laboratory for HAV and HEV, Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, 93053 Regensburg, Germany.ORCID 0000-0003-3782-8226
Institute of Medical Microbiology and Hygiene · DERobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis EHepatitis E virusAnimalsHepatitis AntibodiesHumansImmunoglobulin MRatsRetrospective StudiesRNA, ViralHepatitis AntibodiesImmunoglobulin MRNA, ViralepidemiologyGermanyhepatitis E virusorthohepevirus Cphylogenyrat HEV

Identifiers

PMID35458471
PMCPMC9029421
OpenAlexW4220866012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.